HealthcareServices

Muscle Wasting Disorders Market Future Outlook 2026: Key Drivers and Growth Potential

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the muscle wasting disorders market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Muscle Wasting Disorders Market’s size between 2026 and 2030?

Recently, the market size for muscle wasting disorders has expanded considerably. Projections show it will expand from $17.49 billion in 2025 to $19.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.2%. Key factors contributing to this historical growth include the prevalence of muscular dystrophy and als, the increased use of physical therapy, a rise in nutritional supplement usage, the early adoption of anti-inflammatory treatments, and the growth in hospital-based rehabilitation services.

The muscle wasting disorders market is projected to experience significant expansion shortly. By 2030, this market is anticipated to reach a valuation of $33.5 billion, demonstrating a compound annual growth rate (CAGR) of 13.8%. This projected growth is driven by several factors, including progress in gene therapy techniques, increasing financial commitment to regenerative medicine, the proliferation of specialized rehabilitation facilities, a heightened need for customized treatment approaches, and an elevated emphasis on dietary interventions. Key trends during this period are expected to encompass the growing uptake of gene therapy for muscle regeneration, an increasing reliance on nutritional and protein supplements, a surge in demand for physical rehabilitation programs, the development of more targeted treatments for muscular dystrophy, and a greater application of hormonal and and anti-inflammatory drugs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

Which Drivers Are Shaping Strategic Decisions In The Muscle Wasting Disorders Market?

The increasing adoption of a sedentary lifestyle is anticipated to drive the expansion of the muscle wasting disorders market in the future. This lifestyle is characterized by physical inactivity, with individuals engaging in minimal or no physical movement or exercise. Such behavior negatively affects muscle function, resulting in reduced muscle strength and endurance, thereby contributing to muscle wasting disorders and hindering individuals’ ability to preserve muscle mass and overall function. For instance, in March 2025, as per NHS England, a UK-based executive non-departmental public body, over one-quarter of adults were categorized as inactive, concurrently, in 2023, nearly one-third of children and young people (30.2 percent) performed less than 30 minutes of physical activity each day. Consequently, the increasing adherence to a sedentary lifestyle is propelling the growth of the muscle wasting disorders market.

What Segment Categories Are Covered In The Muscle Wasting Disorders Market?

The muscle wasting disorders market covered in this report is segmented –

1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types

2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types

3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents

2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs

3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements

4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions

5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques

6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices

Which Trends Are Guiding The Evolution Of The Muscle Wasting Disorders Market?

Leading companies active in the muscle wasting disorders market are developing innovative offerings, such as novel gene therapy, to better serve affected patients. Novel gene therapy refers to a medical technology designed to achieve a therapeutic impact by manipulating gene expression or altering the biological characteristics of living cells. As an illustration, in June 2023, Sarepta Therapeutics, a US-based biotechnology company, introduced Elevidys, which represents the first gene therapy sanctioned by the U.S. Food and Drug Administration (FDA) for addressing Duchenne muscular dystrophy (DMD) in pediatric patients between the ages of 4 and 5 years old. Elevidys is a recombinant gene therapy engineered to deliver a gene into the body that results in a truncated protein containing selected domains of the dystrophin protein found in normal muscle cells. This product is administered through a single intravenous infusion.

Which Major Industry Participants Are Leading The Muscle Wasting Disorders Market Growth?

Major companies operating in the muscle wasting disorders market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Cytokinetics Incorporated, Scholar Rock, Akashi Therapeutics, aTyr Pharma, MyoTherix Inc., Pephexia Therapeutics, Biophytis SA, TNF Pharmaceuticals Inc., Rejuvenate Biomed, Edgewise Therapeutics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

Which Region Currently Holds The Largest Share Of The Muscle Wasting Disorders Market?

North America was the largest region in the muscle wasting disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Muscle Wasting Disorders Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13706&type=smp

Browse Through More Reports Similar to the Global Muscle Wasting Disorders Market 2026, By The Business Research Company

Muscle Pain Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Muscle Spasticity Market Report 2026

https://www.thebusinessresearchcompany.com/report/muscle-spasticity-global-market-report

Duchenne Muscular Dystrophy Market Report 2026

https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795